This is an archive article published on April 20, 2021
Premium

Dr Guleria: HCQS, azithromycin still used to treat Covid-19 patients, but no evidence on their benefit

"Last year, HCQS was promoted in a big way but data did not support the use of these drugs and it is not there currently in most guidelines," Dr Guleria said.

A bottle of hydroxychloroquine tablets. (AP Photo/David J. Phillip, File)
A bottle of hydroxychloroquine tablets. (AP Photo/David J. Phillip, File)
3 min readPuneApr 20, 2021 10:38 AM IST First published on: Apr 20, 2021 at 10:35 AM IST

AIIMS Director Dr Randeep Guleria on Tuesday said drugs which were no longer in the national treatment guidelines continue to be administered to Covid-19 patients. Responding to a query from The Indian Express about the use of drugs like hydroxychloroquine (HCQS) and azithromycin, Dr Guleria admitted that in some areas these drugs were being used in addition to ivermectin.

“Data is not very strong and there is no conclusive evidence that these drugs are of any benefit. However, some people use HCQS as it may have some benefit and may not cause harm. The same goes for azithromycin, which is not used as an antibiotic but as an immunomodulator. Both these drugs are used in some areas,” he said.

Anuradha Mascarenhas is a Senior Editor at The Indian Express, based in Pune. With a career spanning... Read More

Latest Comment
Post Comment
Read Comments